Top U.S. proton pump inhibitors' revenue market share 2013

Top proton pump inhibitors based on U.S. revenue market share in 2013

by Statista Research Department, last edited Feb 17, 2014
Top U.S. proton pump inhibitors' revenue market share 2013 This statistic displays the market share of the top ten proton pump inhibitors in the United States in 2013. In that year, Aciphex was among the leading proton pump inhibitors with a total market share of 8 percent in the United States. Proton pump inhibitors are drugs that aid in the long-term reduction of gastric acid production. It is often used to treat conditions such as peptic ulcer disease and Barrett's esophagus.
Show more

Top proton pump inhibitors based on U.S. revenue market share in 2013

Loading statistic...
Market share
Nexium64%
Dexilant9.5%
Aciphex8%
Omeprazole (Rx)7%
Lansoprazole3.3%
Prevacid SoluTab2.5%
Omeprazole/sodium bicarbonate1.3%
Pantoprazole sodium1.1%
Protonix (intravaneous)1.1%
Protonix0.8%
Market share
Nexium64%
Dexilant9.5%
Aciphex8%
Omeprazole (Rx)7%
Lansoprazole3.3%
Prevacid SoluTab2.5%
Omeprazole/sodium bicarbonate1.3%
Pantoprazole sodium1.1%
Protonix (intravaneous)1.1%
Protonix0.8%
Download Settings Share
Download started
Please be patient - this may take a moment
by Statista Research Department, last edited Feb 17, 2014
This statistic displays the market share of the top ten proton pump inhibitors in the United States in 2013. In that year, Aciphex was among the leading proton pump inhibitors with a total market share of 8 percent in the United States. Proton pump inhibitors are drugs that aid in the long-term reduction of gastric acid production. It is often used to treat conditions such as peptic ulcer disease and Barrett's esophagus.
Show more
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Pharmaceutical trends in Europe"
  • Overview
The most important statistics
  • European Pharmaceutical companies
  • Self-medication market
  • Employment
  • Clinical Trials
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.